-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS: INTENDS TO SUBMIT A SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) TO FDA BY YEAR-END 2026

Reuters·12/02/2025 12:30:01

Please log in to view news